Publication | Closed Access
MA03.02 TROPION-PanTumor01: Updated Results From the NSCLC Cohort of the Phase 1 Study of Datopotamab Deruxtecan in Solid Tumors
25
Citations
0
References
2021
Year
Tumor BiologyEndocrine OncologyTumoral PathologyMedicinePathologyMa03.02 Tropion-pantumor01Datopotamab DeruxtecanCancer TreatmentOncologyRadiation OncologyPhase 1Molecular Oncology
No additional data available for this publication yet. Check back later!